Patent · US Active

Sodium channel protein type III α-subunit splice variant

US8252541B2 · kind B2 · utility

0Cited by

45References

9Claims

0Family size

Assignee

Vertex Pharmaceuticals Incorporated · US

Inventors

Kenneth McCormack · Oceanside, US
Christopher Dinesh Raj · San Diego, US

Key dates

Filing date	Feb 1, 2011
Grant date	Aug 28, 2012
Priority date	—
Expiry date	Feb 1, 2031

Classification

Technology area (CPC G)Physics
CPC primaryG01N2500/00
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The present invention is directed to a splice variant of a human sodium channel alpha subunit and methods and compositions for making and using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.